Incarceration of early gravid uterus with adenomyosis and myoma: report of two patients managed with uterine reduction

Although gravid uterine incarceration is typically diagnosed during the early second trimester, we encountered two unusual cases in early pregnancy. A 34-year-old multiparous woman with adenomyosis presented at 7 + 2 weeks of gestation with increased urinary frequency and a sensation of incomplete bladder emptying. The uterine incarceration was successfully reduced by manual reduction and pessary insertion, and she delivered a normal infant at term. In the second case, a 31-year-old nulliparous woman with a large myoma complained of dysuria, acute urinary retention, and intense back pain at 6 weeks of gestation. Manual reduction was successful in the knee-chest position. Subsequent pessary insertion failed; however, a slight reduction in pain was achieved. After a week, the fetus spontaneously aborted. In summary, gravid uterine incarceration is a rare but potentially fatal condition for the fetus, and a suspicion of this condition in patients with urinary symptoms, especially urinary retention and pelvic pain, is important in the early gestation period.

The application of ultrasound visualization in instantly evaluation and supplement therapeutics in the treatment of uterine fibroids and adenomyosis with HIFU / 重庆医学

Objective To investigate the application of ultrasound visualization in instantly evaluation and supplement therapeu-tics in the treatment of uterine fibroids and adenomyosis with high intensity focused ultrasound (HIFU ) .Methods 57 patients with 67 uterine fibroids and 31 patients with 41 adenomyosis were treated with JC-200 HIFU treatment system and monitored the blood flow change in the lesion with B-ultrasound .Evaluated the curative effect with ablation ratio and ablation ratio after supplement therapeutics .Results The average ablation ratio of 57 uterine fibroids was(84 .6 ± 16 .1)% and the increased to(87 .0 ± 10 .7)% af-ter supplement therapeutics to 9 lesions with blood flow in the border of all .The changes were no significance(P>0 .05) .The aver-age ablation ratio of 31 adenomyosis was(62 ± 22 .7)% and increased to(74 ± 14 .7)% after supplement therapeutics to 11 lesions with blood flow in the border of all .The changes were statically significance(P<0 .05) .Conclusion Ultrasound visualization could be used to evaluate the area and extent of ablation with HIFU therapy ,it can clear lesions remaining parts and guiding the supple-ment therapeutics to improve the ablation ratio .Ultrasound visualization provided an evidence of therapeutics in the early period .

Patología uterina y su impacto en la fertilidad / Impact of uterine diseases on fertility

El útero es un órgano fundamental dentro del proceso reproductivo y participa en eventos claves, como el transporte espermático, la implantación y la nutrición fetal. Los miomas uterinos, las anomalías congénitas, los pólipos endometriales y las sinequias uterinas son las principales patologías uterinas en mujeres en edad reproductiva, y pueden ser causa de infertilidad, aborto recurrente o parto prematuro. De acuerdo a la evidencia, el tratamiento quirúrgico de miomas uterinos submucosos e intramurales (que distorsionan la cavidad uterina), pólipos endometriales y sinequias se asocia a un aumento significativo en las tasas de embarazo. El tratamiento quirúrgico del septum uterino disminuye significativamente la probabilidad de aborto a repetición y puede incrementar la probabilidad de embarazo en pacientes sin otra causa aparente de infertilidad. El tratamiento quirúrgico de miomas intramurales y subserosos (que no comprometen la cavidad endometrial) es controvertido y su indicación depende de la evaluación de cada caso en particular.

The uterus exerts an important role in the reproductive process and participates in key events, including sperm migration, embryo implantation and fetal nourishment. Uterine myomas, congenital anomalies, endometrial polyps and uterine synechia are the main diseases affecting women in reproductive age, and display a significant impact as asource of infertility, recurrent abortion or preterm labour. According to evidence, surgical treatment of submucous and intramural myomas (associated to uterine cavity distortion), endometrial polyps and uterine adhesions significantly improves pregnancy rates. Surgical treatment of uterine septum significantly decreases recurrent miscarriage rate and can increase odds of pregnancy in patients with no apparent cause of infertility. Surgical treatment in patients with intramural and subserous myomas (without endometrial cavity distortion) is controversial and treatment should be based on an individual basis.

Clinical study of hysteroscopic surgery for endometrial polyps / 中国基层医药

Objective To determine the clinical valuation of different ways of hysteroscopic surgery for endometrial polyps. Methods Clinical effects were analysed retrospectively on total 86 patients underwent different ways of hysteroscopic surgery according to women physiological stages, the desire of fertility and clinical symptoms, the mean followed-up duration was (18±6) months. Results Among 86 cases, after polyps resected. In 53 cases menstrual change, 48 cases were cured, 5 cases were invalid. In 20 cases dysmenorrhea, 16 cases were valid, 4 cases were invalid. In 22 cases secondary anemia, 18 cases were cured, 4 cases recovered. Conclusions Fertile stage: uterine curettage should be undergone for patients without menstrual change after polyps resected; among patients with menstrual change, whole layer of endometria were resected for the ones (more than 40 ages) without desire of fertility and superficial layer of endometria were resected for the others after polyps resected. Perimenopause: uterine curettage should be undergone for patients without menstrual change and whole layer of endometria were reacted for patients with menstrual change after polyps resected. Postmenopause: uterine curettage should be undergone for patients without vaginal bleeding and endometria ablation should be carried out for patients with vaginal bleeding.